Novus Global as of late declares the approaching retirement of Dr. Uwe Ranft from his function as managing director of Europe, the Heart East and Africa (EMEA) and world strategic accounts. Dr. Volker Seidl will prevail him, bringing twenty years of intensive revel in to the function.
“NOVUS has been lucky to have Uwe with us for the previous twenty years, with 14 of the ones on the helm of the industrial trade in EMEA,” says Senior Vice President & Leader Business Officer Ed Galo. “Beneath his management, NOVUS has reinforced its relationships with key accounts and grown its place as a pace-setter in clever diet answers during Europe, the Heart East, and Africa. We will’t thank him sufficient for his years of provider and willpower to his shoppers and associates.”
Dr. Seidl joined NOVUS because the director of world strategic accounts in 2021. On the time, his intensive revel in within the chemical and animal diet industries incorporated head of gross sales excellence and head of world key account control at BASF Animal Diet.
In his new function, Dr. Seidl will lend a hand information NOVUS’ industrial technique inside EMEA. Along with his responsibility for the worldwide strategic accounts trade, he’ll organize the EMEA gross sales and technical groups, leverage assets, and align company purposes to reinforce trade enlargement and ship price to shoppers.
All over his tenure with NOVUS, Dr. Seidl has confirmed himself able for this new skilled alternative, Galo says.
“Volker has effectively led efforts to fortify partnerships and develop trade with world strategic accounts,” he says. “He’s added price to the buyer through creating and executing a unified framework to spot and organize strategic accounts in any respect ranges of our group. He’s the best chief to proceed this transformative paintings as the pinnacle of the industrial trade in EMEA and with our world strategic accounts.”
The transition duration will start straight away and proceed via January 1, 2024, when Dr. Seidl’s appointment takes impact. On January 1, Dr. Ranft will transfer to a senior advisory function and proceed to reinforce the transition and the trade via his retirement date, March 31, 2024.
September 5, 2023 – NOVUS